Global private equity and venture capital news and research


11 May 2016

Longitude launches third life sciences fund with $525m target

health Menlo Park-based venture capital firm Longitude Capital is looking to raise up to $525m for its third life sciences fund, AltAssets can reveal.

10 May 2016

Accel leads $12m Series B round for Israel’s E8 Storage

Computer_software_tech Global venture capital investor Accel Partners has led a $12m financing round for Tel Aviv-based E8 Storage less than a month after raising $500m for an Israel-focused fund.

10 May 2016

Next World’s second fund edges towards $125m goal

world-549425_1920 San Francisco-based Next World Capital is within touching distance of its second fund’s $125m target, AltAssets understands.

10 May 2016

Rethink Education reels in $67m towards Fund II raise

pencil-918449_1920 Education tech-focused Rethink Education has pulled in at least $67m for its $125m-targeting second fund.

10 May 2016

Cross Culture Ventures raises $10.5m for first fund

Troy Carter, Cross Culture Ventures Cross Culture Ventures, a VC firm founded by three African-American partners including Lady Gaga's long-term manager Troy Carter, has collected $10.5m for its first fund.

9 May 2016

Amadeus, Albion back Relayware’s US growth with $11m investment

coins-431537_640 Amadeus Capital Partners has led an $11m investment in Relayware alongside existing venture capitalist investor Albion Ventures>

9 May 2016

Highland lead $7m round in storage startup Omni

fish-boxes-988590_960_720 Venture capital firm Highland Capital has led a $7m Series A financing round in personal storage startup Omni.

9 May 2016

Strategic LP trio help venBio Partners to $315m Fund II close

stem-cell-163711_1280 San Francisco-based life sciences investment firm venBio Partners has raised $315m for its second fund thanks to anchor investments from strategic LPs including Amgen, Merck and Baxalta.

9 May 2016 raises $60m for US fund

dollar-bill-1088855_1920 Global venture capital firm has collected at least $60m for its latest US-focused fund, AltAssets can reveal.

9 May 2016

CDIB Capital co-leads $12.5m Series B for cancer molecular info business ACT Genomics

dna-1015661_1920 China-based CDIB Capital Management has co-led a $12.5m Series B financing round for ACT Genomics, a molecular information company aiming to transform precision cancer care.

Page 30 of 884« First...1020...2829303132...405060...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016